Sign Up to like & get recommendations! 0
Published in 2018 at "JAMA Cardiology"
DOI: 10.1001/jamacardio.2017.4625
Abstract: Importance Physicians need information on how to use the first available high-sensitivity troponin (hsTnT) assay in the United States to identify patients at very low risk for 30-day adverse cardiac events (ACE). Objective To determine… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "JAMA Cardiology"
DOI: 10.1001/jamacardio.2018.3408
Abstract: Importance Loading doses of atorvastatin did not show reduction on clinical outcomes in the overall population of patients with acute coronary syndrome (ACS) enrolled in the Statins Evaluation in Coronary Procedures and Revascularization (SECURE-PCI) trial,… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2021.22597
Abstract: Key Points Question Is dual antiplatelet therapy with acetylsalicylic acid (ASA) and ticagrelor associated with better clinical outcomes for patients with acute coronary syndrome treated with coronary artery bypass grafting compared with ASA monotherapy? Findings… read more here.
Sign Up to like & get recommendations! 3
Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.55709
Abstract: Key Points Question Is short-term oral rivaroxaban a noninferior alternative to parenteral enoxaparin in the acute phase of acute coronary syndrome (ACS)? Findings This equivalence and noninferiority trial including 2046 patients found that short-term rivaroxaban… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2024.11159
Abstract: This systematic review and meta-analysis investigates clinical outcomes and postdischarge treatment after acute coronary syndromes or revascularization among people living with HIV. read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2024.13946
Abstract: This secondary analysis of a randomized clinical trial investigates the association of COVID-19 vaccination with incidence of cardiopulmonary events among patients who had experienced acute coronary syndromes. read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2024.48389
Abstract: This cohort study compares the cardiovascular and major bleeding outcomes of prasugrel vs ticagrelor among new users undergoing invasive treatment for acute coronary syndrome. read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2025.37334
Abstract: This cohort study examines trends in the use of heated tobacco products and their association with hospitalizations for acute coronary syndrome among Japanese adults from 2013 to 2022. read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Journal of the American Association of Nurse Practitioners"
DOI: 10.1002/2327-6924.12438
Abstract: Purpose We review the use of oral antiplatelet (OAP) therapies in acute coronary syndrome (ACS) management for nurse practitioners (NPs), focusing on current guideline recommendations. Data sources Treatment guidelines and clinical articles from PubMed. Conclusions… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Annals of Neurology"
DOI: 10.1002/ana.26646
Abstract: A 54-year-old woman, active smoker, presented to the emergency department (ED) because of chest pain and shortness of breath. Both the blood test for myocardial enzymes and the electrocardiogram supported the diagnosis of acute coronary… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "British Journal of Clinical Pharmacology"
DOI: 10.1002/bcp.70072
Abstract: Although guidelines recommend in‐hospital initiation of high‐intensity statin therapy in patients with acute coronary syndromes (ACS), low‐density lipoprotein cholesterol (LDL‐C) target levels are frequently not attained. Alirocumab has been demonstrated to be a fast‐acting and… read more here.